<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en" xmlns:epub="http://www.idpf.org/2007/ops">
<head>
	<meta charset="utf-8"/>
	<title>Cancer Treatment</title>
	<meta name="description" content=""/>
	<meta name="viewport" content="width=device-width, initial-scale=1"/>
	<link rel="stylesheet" type="text/css" href="../vcsprod_20221215125633UTC-prod/skins_20221215125633UTC-prod/vcs/css/vcs.css"/>
</head>
<body>
<div epub:type="pagebreak" id="pagebreak_266" class="hidden-pagebreak" title="266" xmlns:epub="http://www.idpf.org/2007/ops" />
<script type="text/JavaScript" src="../vcsprod_20221215125633UTC-prod/vcsengines_20221215125633UTC-prod.js"></script>
<div  xmlns:epub="http://www.idpf.org/2007/ops" id="08cbe02a-d2cc-4e65-b0e6-87bf96e9e734" class="screen rendered">
		<div class="screengrid">
			<header class="screen__margin screen__header u-hide-element vstdonthighlight">
				
					<div class="screen__heading u-float--clearfix">
						<div class="screen__icon u-float--left"></div>
						<h2 class="screen__title" tabindex="-1"></h2>
					</div>
				

				<div class="screen__instructions"></div>
			</header>
		</div>
		
			<div class="screen__content">
				
			<div class="block rendered">
		<div id="05933938-cbd7-4322-a69d-0eb56c4aa457" class="block-content engine"><div class="static">
		<div class="screen__margin">
			
			<h3 class="heading heading--subheadinga"><span style="color:#684182;"><strong>CANCER TREATMENT</strong></span><br /></h3>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="5e6c6aa8-108b-4d8b-8d26-1a01b266afe1" class="block-content engine"><div class="static">
		<div class="screen__margin">
			<div class="static__text--indent">
				<p>Major approaches to cancer treatment are <strong>surgery, radiation therapy, chemotherapy, molecularly targeted therapy, </strong>and <strong>immunotherapy.</strong> Each <strong>modality </strong>(method) may be used alone, but often they are used together in combined-modality regimens to improve the overall diagnosis and treatment result.</p>
			</div>

		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="09d9feff-0dd7-4b12-9895-bc23f1d8b87b" class="block-content engine"><div class="static">
		<div class="screen__margin">
			
			<h3 class="heading heading--subheadinga"><span style="color:#007FAD;">SURGERY</span><br /></h3>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="2a70064a-93c2-4f5e-aad4-3a620214eef1" class="block-content engine"><div class="static">
		<div class="screen__margin">
			<div class="static__text--indent">
				<p>In many patients with cancer, the tumor is discovered before it has spread, and it may be cured by surgical excision. Some common cancers in which surgery may be curative are those of the stomach, breast, colon, lung, and uterus (endometrium). In other patients who have metastases, surgical removal of the primary tumor prevents local spread or complications, even in the presence of distant disease. A <strong>debulking procedure</strong> may be used to remove as much of the primary tumor mass as possible, even if the tumor is attached to a vital organ and cannot be completely removed. After removal of the primary tumor, the patient often receives <strong>adjuvant </strong>(assisting) radiation therapy and/or chemotherapy to prevent recurrence at local and distant sites.</p><p>The following is a list of terms that describe surgical procedures used in diagnosing and treating cancer.</p>
			</div>

		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="2e968b0a-9863-45f8-bff8-831c46792848" class="block-content engine"><div class="static">
		<div class="screen__margin vst-draggable">
			<div class="c-x-scroll vst-draggable">
					<div class="js-x-scroll c-x-scroll__scrollbox" style=""><table class="c-table js-x-scroll-component" style="width: 100%;" data-orig-width="100%"><thead></thead><tbody><tr><td><strong>cauterization</strong></td><td>Destruction of tissue by burning. Examples are electrocauterization (using a needle or snare heated by electric current), laser, dry ice, and chemicals.</td></tr><tr><td><strong>core needle biopsy</strong></td><td>Placement of a large-bore needle that extracts a core of tissue.</td></tr><tr><td><strong>cryosurgery</strong></td><td>Use of subfreezing temperature to destroy tissue.</td></tr><tr><td><strong>en bloc resection</strong></td><td>Tumor is removed along with a large area of surrounding tissue containing lymph nodes. Modified radical mastectomy, colectomy, and gastrectomy are examples.</td></tr><tr><td><strong>excisional biopsy</strong></td><td>Removal of tumor and a margin of normal tissue. This procedure provides a specimen for diagnosis and may be curative for small noninvasive tumors.</td></tr><tr><td><strong>exenteration</strong></td><td>Wide resection involving removal of the tumor, its organ of origin, and all surrounding tissue in the body space. Pelvic exenteration with removal of the uterus, ovaries, bladder, and segments of the large bowel may be performed to treat large primary tumors of the uterus.</td></tr><tr><td><strong>fine needle aspiration</strong></td><td>Placement of a very thin needle inside the tumor mass and extracting cells for microscopic evaluation.</td></tr><tr><td><strong>fulguration</strong></td><td>Destruction of tissue by electric sparks generated by a high-frequency current.</td></tr><tr><td><strong>incisional biopsy</strong></td><td>Piece of tumor is removed for examination to establish a diagnosis. More extensive surgical procedure or other forms of treatment, such as chemotherapy or radiation therapy, are then used to treat the bulk of the tumor.</td></tr></tbody></table></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--left"></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--right"></div>
				</div>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="91a4bf65-e909-4ad1-9398-d147992f5293" class="block-content engine"><div class="static">
		<div class="screen__margin">
			
			<h3 class="heading heading--subheadinga"><span style="color:#007FAD;">RADIATION THERAPY (RADIATION ONCOLOGY)</span><br /></h3>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="aa69478a-33a6-4571-81df-0657b8614d4e" class="block-content engine"><div class="static">
		<div class="screen__margin">
			<div class="static__text--indent">
				<p>The <strong>goal of radiation therapy (RT)</strong> is to deliver a maximal dose of ionizing radiation to the tumor tissue and a minimal dose to the surrounding normal tissue. High-dose <strong>irradiation</strong> (exposure of tissue to radiation) destroys tumor cells and produces damage to DNA. Newer techniques of irradiation use high-energy beams of <strong>protons </strong>(subatomic particles) to improve the uniformity (conformality) of dose and to limit damage to normal tissues.</p><p>Terms used in the field of radiation therapy for cancer are as follows:</p>
			</div>

		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="17286944-ac54-4bda-94db-0b1ba8a948ec" class="block-content engine"><div class="static">
		<div class="screen__margin vst-draggable">
			<div class="c-x-scroll vst-draggable">
					<div class="js-x-scroll c-x-scroll__scrollbox" style=""><table class="c-table js-x-scroll-component" style="width: 100%;" data-orig-width="100%"><thead></thead><tbody><tr><td><strong>brachytherapy</strong></td><td>Implantation of small, sealed containers or seeds of radioactive material directly into the tumor (interstitial therapy); or in a cavity of the tumor (intracavitary therapy, as in endometrial cancer). An implant may be temporary (as in treatment for tumors of the head and neck or gynecologic malignancies) or permanent (as with prostatic implants, or “seeds,” placed into the affected area of the gland).</td></tr><tr><td><strong>electron beams</strong></td><td>Low-energy beams for treatment of skin or surface tumors.</td></tr><tr><td><strong>external beam irradiation (teletherapy)</strong></td><td>Radiation therapy applied to a tumor from a distant source (linear accelerator).</td></tr><tr><td><strong>fractionation</strong></td><td>A method of dividing radiation into small, repeated doses rather than fewer large doses. Fractionation allows larger total doses to be given while causing less damage to normal tissue.</td></tr><tr><td><strong>gray (Gy)</strong></td><td>Unit of absorbed radiation dose. Historically, the unit in use was rad (100 rad equal 1 Gy).</td></tr><tr><td><strong>linear accelerator</strong></td><td>Large electronic device that produces high-energy x-ray (or photon) beams for the treatment of deep-seated tumors (Figure 19-9). Intraoperative radiation therapy (IORT) is direct application of radiation during surgery using a linear accelerator in the operating room.</td></tr><tr><td><strong>photon therapy</strong></td><td>Radiation therapy using x-rays or gamma rays. A linear accelerator produces photon beams to treat tumors. See <em><strong>In Person: Radiotherapy</strong></em>.</td></tr></tbody></table></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--left"></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--right"></div>
				</div>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="89620104-2057-42f4-9c06-de41050a3a82" class="block-content engine"><div class="static u-float--clearfix screen__margin">
		<figure class="fig fig--50 fig--center">
		    <div class="image-zoom-holder">
		<img class="zoomable-image vst-click disabled" src="../media/page_629_02.jpg" alt="" /><img class="image-zoom-proxy" src="../media/page_629_02.jpg" style="display: none;" />
		<button class="image-zoom-button" style="display: none;"><span class="visuallyhidden">zoom image</span></button>
	</div>
		    <figcaption class="fig-caption fig__caption--bottom"><p><strong><span style="color:#D81E5D;">FIGURE 19-9 </span>Linear accelerator.</strong> Radiation therapy (photon therapy) delivered to a patient positioned under a linear accelerator.<strong> Intensity-modulated radiation therapy (IMRT) </strong>is an advanced mode of high-precision radiotherapy that uses computercontrolled linear accelerators to deliver precise radiation doses to a malignant tumor. This is a type of <strong>conformal radiation therapy</strong> that uses computer technology to create a three-dimensional image of a tumor so that rotating beams can shape exactly to the contour of the tumor. <em>(Courtesy Arthur Brimberg, MD, Riverhill Radiation Oncology, Yonkers, New York.)</em></p></figcaption>
		</figure>
	</div></div>
		
	</div><div class="block rendered">
		<div id="8231f011-37ee-4e6e-bf5a-55acf4a07c8a" class="block-content engine"><div class="static">
		<div class="screen__margin vst-draggable">
			<div class="c-x-scroll vst-draggable">
					<div class="js-x-scroll c-x-scroll__scrollbox" style=""><table class="c-table js-x-scroll-component" style="width: 100%;" data-orig-width="100%"><thead></thead><tbody><tr><td><strong>proton therapy</strong></td><td>Small subatomic positively charged particles (protons) produced by a cyclotron deposit all the energy at a focused finite point. This reduces the dose affecting normal surrounding tissues by at least 50% (Figure 19-10).</td></tr><tr><td><strong>radiation fields</strong></td><td>Dimensions of the size of radiation area used to treat a tumor from a specific angle. See Figure 19-11.</td></tr><tr><td><strong>radiocurable tumor</strong></td><td>Tumor that can be completely eradicated by radiation therapy. Usually, this is a localized tumor with no evidence of metastasis. Lymphomas, Hodgkin lymphoma, and seminomas of the testes are examples.</td></tr><tr><td><strong>radioresistant tumor</strong></td><td>Tumor that requires large doses of radiation to produce death of the cells. Melanoma and renal carcinoma are among the most radioresistant tumors.</td></tr><tr><td><strong>radiosensitive tumor</strong></td><td>Tumor in which irradiation can cause the death of cells without serious damage to surrounding tissue (morbidity). Tumors of hematopoietic (blood-forming) and lymphatic origins are radiosensitive.</td></tr><tr><td><strong>radiosensitizers</strong></td><td>Drugs that increase the sensitivity of tumors to x-rays. Many cancer chemotherapy drugs, especially 5-fluorouracil and cisplatin, sensitize tumors and normal tissue to radiation, thereby improving the outcome of treatment.</td></tr><tr><td><strong>radiosensitizers</strong></td><td>An imaging study performed before radiation therapy using CT scan and/or MRI to map the area to receive treatment. Simulation is required for all patients undergoing radiotherapy.</td></tr><tr><td><strong>stereotactic radiosurgery</strong></td><td>Single large dose of radiation is delivered under precise three-dimensional (3D) guidance (stereotactic) from multiple angles to destroy vascular abnormalities and small brain tumors (see Figure 19-10B).</td></tr></tbody></table></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--left"></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--right"></div>
				</div>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="46e29d8c-0cd5-4560-95b6-2b5c5bfe67a3" class="block-content engine"><div class="static u-float--clearfix screen__margin">
		<figure class="fig fig--75 fig--center">
		    <div class="image-zoom-holder">
		<img class="zoomable-image vst-click disabled" src="../media/chp00019_f019-010-9780323551472.jpg" alt="" /><img class="image-zoom-proxy" src="../media/chp00019_f019-010-9780323551472.jpg" style="display: none;" />
		<button class="image-zoom-button" style="display: none;"><span class="visuallyhidden">zoom image</span></button>
	</div>
		    <figcaption class="fig-caption fig__caption--bottom"><p><strong><span style="color:#D81E5D;">FIGURE 19-10 </span>A, Proton therapy machine. </strong>Proton beam radiation therapy is useful in treating a variety of cancers including tumors of the head and neck, brain, eye, and prostate. The beam can rotate to different positions around the patient. <strong>B, Proton stereotactic radiosurgery.</strong> A model poses to show how a proton beam device is brought near a patient in preparation for stereotactic radiosurgery. <em>(Courtesy Jay Loeffler, MD, Chief, Radiation Oncology Department, Massachusetts General Hospital, Boston.)</em></p></figcaption>
		</figure>
	</div></div>
		
	</div><div class="block rendered">
		<div id="0d10e292-0e2c-427a-9b6b-69bc18f924ff" class="block-content engine"><div class="static u-float--clearfix screen__margin">
		<figure class="fig fig--75 fig--center">
		    <div class="image-zoom-holder">
		<img class="zoomable-image vst-click disabled" src="../media/chp00019_f019-011-9780323551472.jpg" alt="" /><img class="image-zoom-proxy" src="../media/chp00019_f019-011-9780323551472.jpg" style="display: none;" />
		<button class="image-zoom-button" style="display: none;"><span class="visuallyhidden">zoom image</span></button>
	</div>
		    <figcaption class="fig-caption fig__caption--bottom"><p><strong><span style="color:#D81E5D;">FIGURE 19-11 </span>Radiation fields.</strong> Three-color radiation dose distribution image showing radiation fields used to treat a brain tumor. <em>(Courtesy of Jay Loeffler, MD, Chief, Radiation Oncology Department, Massachusetts General Hospital, Boston.)</em></p></figcaption>
		</figure>
	</div></div>
		
	</div><div class="block rendered">
		<div id="9999f016-2aff-4a40-8929-e1761ba3a290" class="block-content engine"><div class="static">
		<div class="screen__margin">
			<div class="static__text--indent">
				<p>Radiotherapy, although it may be either <strong>palliative </strong>(relieving symptoms) or curative, can produce undesirable side effects to any normal body tissues that are caught in the field of irradiation. Some complications due to irradiation of normal tissue surrounding the tumor and in the path of the beam of photons may be reversible with time, and recovery takes place soon after radiotherapy is completed. Side effects may be acute (days to weeks after first dose), subacute (several weeks or months later), or late (months to years later). Radiation side effects are listed in Table 19-6.</p>
			</div>

		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="ef318a28-b6be-4911-9547-61f0e68c8813" class="block-content engine"><div class="static">
		<div class="screen__margin">
			
			<h3 class="heading heading--subheadinga"><span style="color:#007FAD;"><strong>TABLE 19-6</strong> RADIOTHERAPY SIDE EFFECTS</span></h3>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="9faae86b-cb9d-4e36-bd71-ed7c74714df3" class="block-content engine"><div class="static">
		<div class="screen__margin vst-draggable">
			<div class="c-x-scroll vst-draggable">
					<div class="js-x-scroll c-x-scroll__scrollbox" style=""><table class="c-table js-x-scroll-component" style="width: 100%;" data-orig-width="100%"><thead></thead><tbody><tr><td colspan="2"><strong>Acute</strong></td></tr><tr><td><ul><li><strong>mucositis</strong><br /> </li></ul></td><td><p>inflammation and ulceration of mucous membranes (mouth, pharynx, vagina, bladder, large or small intestine)</p></td></tr><tr><td><ul><li><strong>myelosuppression</strong></li></ul></td><td><p>bone marrow depression (anemia, leukopenia, and thrombocytopenia)</p></td></tr><tr><td><ul><li><strong>nausea and vomiting</strong></li></ul></td><td><p>uneasiness of the stomach and emptying of its contents— more common with irradiation of the brain and gastrointestinal tract</p></td></tr><tr><td><ul><li><strong>xerostomia</strong></li></ul></td><td><p>dryness of the mouth—with salivary gland irradiation</p></td></tr><tr><td colspan="2"><strong>Subacute</strong></td></tr><tr><td><ul><li><strong>alopecia</strong></li></ul></td><td><p>baldness (permanent or temporary)</p></td></tr><tr><td><ul><li><strong>cystitis</strong></li></ul></td><td><p>inflammation of the urinary bladder</p></td></tr><tr><td><ul><li><strong>pneumonitis</strong></li></ul></td><td><p>inflammation of the lungs</p></td></tr><tr><td><ul><li><strong>proctitis</strong></li></ul></td><td><p>inflammation of the rectum and anus</p></td></tr><tr><td colspan="2"><strong>Late</strong></td></tr><tr><td><ul><li><strong>fibrosis</strong></li></ul></td><td><p>increase of connective tissue (scarring of skin, lungs, kidneys)</p></td></tr><tr><td><ul><li><strong>secondary tumors</strong></li></ul></td><td><p>new types of tumors in separate sites (leukemias and solid tumors such as carcinomas and sarcomas)</p></td></tr><tr><td><ul><li><strong>infertility</strong></li></ul></td><td><p>loss of reproductive function</p></td></tr></tbody></table></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--left"></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--right"></div>
				</div>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="baedc06e-6b41-468f-be7f-281d32b8b8a1" class="block-content engine"><div class="static">
		<div class="screen__margin">
			
			<h3 class="heading heading--subheadinga"><span style="color:#007FAD;">CHEMOTHERAPY</span><br /></h3>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="e4e47a4b-29a6-42b1-aa1d-cdab163fd44e" class="block-content engine"><div class="static">
		<div class="screen__margin">
			<div class="static__text--indent">
				<p><strong>Cancer chemotherapy</strong> is the treatment of cancer using chemicals (drugs). It is the standard treatment for many types of cancer, and is curative in a number of them, such as testicular cancer, acute lymphocytic leukemia (children), and Hodgkin lymphoma, and large cell lymphomas. Chemotherapy may be used alone or in combination with surgery and irradiation to improve cure rates.</p><p>Drugs cause tumor cells to die by damaging their DNA. Tumor cells with damaged DNA undergo apoptosis (self-destruction). This means that they have less capacity to repair their DNA and, in general, are less able to survive DNA damage caused by drugs and radiation.</p><p>The ideal is to administer drugs that kill large numbers of tumor cells without harming normal cells. However, rapidly dividing normal cells, such as in the bone marrow and gastrointestinal lining, can suffer considerable damage from chemotherapeutic drugs. Research physicians measure drug levels and disappearance from the bloodstream and tissues. They use information from animal experiments and <strong>clinical trials <img alt="" class="c-inline-icon" data-handler="inline-image" style="vertical-align: middle; width: 16px; height: 16px;" src="../media/icons.png" data-handler-handled="true" /></strong> to design better routes and schedules of administration to achieve the greatest tumor kill with the least toxicity (harm) to normal cells.</p><p><strong>Combination chemotherapy </strong>is the use of two or more drugs together to kill tumors. Drugs are given according to a written <strong>protocol</strong>, or plan, that details the route, schedule, and frequency of doses. Usually, drug therapy is continued until the patient achieves a complete <strong>remission </strong>(absence of all signs of disease).<strong> Adjuvant chemotherapy</strong> is the administration of drug treatment after surgery to kill any residual cancer cells. <strong>Neoadjuvant chemotherapy </strong>is administrated before surgery to reduce the size of a tumor, such as breast or head and neck cancer. Neoadjuvant drug treatment allows for a lesser surgery and improvement of outcome.</p><p>The following are categories of cancer chemotherapeutic agents. Each works by disrupting cell function so that cancer cells die. At the same time, normal cells may be damaged as well. In each category, side effects such as alopecia, nausea and vomiting, and myelosuppression (suppression of bone marrow) can occur.</p><ol><li><strong>Alkylating agents.</strong> These drugs cause crosslinks and breaks in DNA that interfere with cell division. <strong>Cisplatin (Platinol) </strong>and <strong>cyclophosphamide (Cytoxan) </strong>are examples.</li><li><strong>Antibiotics.</strong> These drugs are produced by bacteria or fungi and inhibit cell division by causing breaks in DNA strands. <strong>Doxorubicin (Adriamycin)</strong> is an example.</li><li><strong>Antimetabolites. </strong>These drugs block synthesis of DNA components (nucleotides) and prevent cells from dividing. <strong>Methotrexate and 5-fluorouracil (5FU)</strong> are examples.</li><li><strong>Antimitotics.</strong> These chemicals block the function of a protein that is necessary for mitosis (cell division). Antimitotic drugs are derived from bacteria, fungi or plants, or from small sea animals found on coral reefs.<strong> Paclitaxel (Taxol) </strong>is an example.</li><li><strong>Hormonal agents. </strong>These drugs block hormone receptors on cells so that growth is inhibited. An example is <strong>tamoxifen (Novadex)</strong>, which blocks an <strong>estrogen receptor </strong>on breast cancer cells. Aromatase inhibitors, such as<strong> anastrozole (Arimidex)</strong> prevent the conversion of androgen to estrogen and starve breast tumors of their estrogen supply in women who have gone through menopause (age greater than 50).</li></ol><p>Figure 19-12 illustrates the mechanisms of action for various types of cancer che motherapeutic agents. Often, drugs are administered in combination, according to carefully planned <strong>protocols </strong>(regimens). For your reference, see Table 19-7 which lists specific chemotherapeutic drugs in each category and the type of cancer they treat.</p>
			</div>

		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="3d8090dd-8cf7-43e1-8551-813a79d2a0bb" class="block-content engine"><div class="static">
		<div class="screen__margin">
			<div class="static__text--indent">
				<p><img alt="" class="c-inline-icon" data-handler="inline-image" style="vertical-align: middle; width: 16px; height: 16px;" src="../media/icons.png" data-handler-handled="true" /> <strong>Clinical Trials</strong>: Clinical trials are research studies designed to find treatments that work better than the standard therapies for patients. The studies follow a predefined protocol and are divided into four phases:</p><p style="margin-left: 40px;"><strong>Phase I:</strong> The experimental drug or treatment is tested in a small group of people (20 to 80) for the first time to evaluate its safety. Phase I trials also determine a safe dosage range and schedule of administration (daily, weekly, or every 3 weeks, oral or intravenous, and so on).</p><p style="margin-left: 40px;"><strong>Phase II:</strong> Experimental treatment is given to a larger group of subjects (100–200) with a specific type of cancer to identify tumor response rate and define safety risks.</p><p style="margin-left: 40px;"><strong>Phase III: </strong>A larger and more definitive trial is conducted in which hundreds or thousands of subjects take part. Patients are randomly assigned to the new treatment or to a standard, established treatment. The effectiveness and overall risk-versus-benefit ratio for the experimental treatment are compared with the results of those for standard treatment. A new drug may be approved by the FDA (U.S. Food and Drug Administration) based on these results.</p><p style="margin-left: 40px;"><strong>Phase IV: </strong>Large studies are conducted after the FDA has granted its initial approval of a new treatment for marketing. These trials are designed to monitor safety in large populations and identify new indications and new drug combinations beyond those already approved.</p>
			</div>

		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="f2a66399-644c-42ab-b720-7c393e514844" class="block-content engine"><div class="static u-float--clearfix screen__margin">
		<figure class="fig fig--75 fig--center">
		    <div class="image-zoom-holder">
		<img class="zoomable-image vst-click disabled" src="../media/chp00019_f019-012-9780323551472.jpg" alt="" /><img class="image-zoom-proxy" src="../media/chp00019_f019-012-9780323551472.jpg" style="display: none;" />
		<button class="image-zoom-button" style="display: none;"><span class="visuallyhidden">zoom image</span></button>
	</div>
		    <figcaption class="fig-caption fig__caption--bottom"><p><strong><span style="color:#D81E5D;">FIGURE 19-12 </span>Mechanisms of action of cancer chemotherapeutic agents.</strong></p></figcaption>
		</figure>
	</div></div>
		
	</div><div class="block rendered">
		<div id="e0b078d1-8ace-41a6-8663-33760f643ac1" class="block-content engine"><div class="static">
		<div class="screen__margin">
			
			<h3 class="heading heading--subheadinga"><span style="color:#007FAD;"><strong>TABLE 19-7</strong> SELECTED CANCER CHEMOTHERAPEUTIC AGENTS AND THE CANCERS THEY TREAT</span></h3>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="4d6b27fa-e32b-42ff-971e-acbda03b3784" class="block-content engine"><div class="static">
		<div class="screen__margin vst-draggable">
			<div class="c-x-scroll vst-draggable">
					<div class="js-x-scroll c-x-scroll__scrollbox" style=""><table class="c-table js-x-scroll-component" style="width: 100%;" data-orig-width="100%"><thead><tr><th scope="col"><strong>CHEMOTHERAPEUTIC AGENT</strong></th><th scope="col"><strong>TYPE OF CANCER</strong></th></tr></thead><tbody><tr><td colspan="2"><strong>Alkylating Agents</strong></td></tr><tr><td>Bendamustine (Ribomustine)</td><td>Non-Hodgkin lymphoma</td></tr><tr><td>Cisplatin (Platinol)</td><td>Testicular; ovarian</td></tr><tr><td>Cyclophosphamide (Cytoxan)</td><td>Lymphoma</td></tr><tr><td>Temozolomide (Temodar)</td><td>Brain (glioma)</td></tr><tr><td colspan="2"><strong>Antibiotics</strong></td></tr><tr><td>Bleomycin (Blenoxane)</td><td>Testicular, Hodgkin lymphoma</td></tr><tr><td>Daunorubicin (Cerubidine)</td><td>Acute myeloid leukemia (AML)</td></tr><tr><td>Doxorubicin (Adriamycin, Doxil)</td><td>Breast</td></tr><tr><td colspan="2"><strong>Antimetabolites</strong></td></tr><tr><td>Cytarabine (ara-C, Cytosar-U)</td><td>AML</td></tr><tr><td>Fludarabine (Fludara)</td><td>Chronic lymphoid leukemia (CLL)</td></tr><tr><td>5-Fluorouracil (5-FU) (various)</td><td>Colon</td></tr><tr><td>Methotrexate, MTX (Folex, Mexate)</td><td>Acute lymphoid leukemia (ALL)</td></tr><tr><td>Pemetrexed (Alimta)</td><td>Lung</td></tr><tr><td><strong>Antimitotics</strong></td><td> </td></tr><tr><td>Docetaxel (Taxotere)</td><td>Breast, lung</td></tr><tr><td>Paclitaxel (Taxol)</td><td>Breast, ovarian, lung</td></tr><tr><td>Vincristine (Oncovin)</td><td>Lymphoma</td></tr><tr><td colspan="2"><strong>Hormones and Hormone Antagonists</strong></td></tr><tr><td>Abiraterone (Zytiga)</td><td>Prostate</td></tr><tr><td>Anastrozole (Arimidex)</td><td>Breast</td></tr><tr><td>Dexamethasone (Decadron)</td><td>Lymphoma</td></tr><tr><td>Leuprolide (Lupron)</td><td>Prostate</td></tr><tr><td>Tamoxifen (Nolvadex)</td><td>Breast</td></tr></tbody></table></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--left"></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--right"></div>
				</div><p><em>Note</em>: Brand names are in parentheses. Often drugs are given in combinations according to carefully planned regimens called <strong>protocols</strong>.</p>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="b2bcd353-a888-44e3-8e1b-bc86372e5483" class="block-content engine"><div class="static">
		<div class="screen__margin">
			
			<h3 class="heading heading--subheadinga"><span style="color:#007FAD;">MOLECULARLY TARGETED THERAPY</span><br /></h3>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="3bf1a03e-7965-4748-9cc3-3f2720b5748c" class="block-content engine"><div class="static">
		<div class="screen__margin">
			<div class="static__text--indent">
				<p>Molecularly targeted cancer therapy uses drugs to attack specific oncogenic mutations (targets) that drive cancer cell growth. When these targets are blocked by drugs, the cancer cell dies. Some of the targets are absolutely unique to tumor cells and not found in normal tissues. Thus, in contrast with chemotherapy, blocking these targets will have little or no effect on normal cells. Chemotherapeutic drugs normally are delivered by intravenous infusion, whereas molecularly targeted drugs <img alt="" class="c-inline-icon" data-handler="inline-image" style="vertical-align: middle; width: 16px; height: 16px;" src="../media/icons.png" data-handler-handled="true" /> often are mostly given in pill form.</p>
			</div>

		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="f6fd2f52-70dc-457c-bd61-135ce91f9428" class="block-content engine"><div class="static">
		<div class="screen__margin">
			
			<h3 class="heading heading--subheadinga"><span style="color:#007FAD;">IMMUNOTHERAPY</span><br /></h3>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="2deaefea-6c2d-499d-b79b-f90ebe8204a0" class="block-content engine"><div class="static">
		<div class="screen__margin">
			<div class="static__text--indent">
				<p>Immunotherapy is the use of immune cells (lymphocytes) or antibodies, to kill tumors. It is now possible to remove a patient’s own T cell lymphocytes and, in the laboratory, introduce new receptors,<strong> CARs (chimeric antigen receptors)</strong>, on their cell surface. These CAR receptors are designed to bind to the CD19 protein found on the surface of all B-cell tumors. The engineered <strong>CAR T-cells</strong> can then be infused into the patient, where they attack and destroy the patient’s B-cell tumors. This therapy is effective against all B-cell tumors, including acute lymphoid leukemia (ALL), chronic lymphoid leukemia (CLL), and lymphomas.</p><p>Other immunotherapies depend on laboratory engineered antibodies, called monoclonal antibodies. These <strong>monoclonal antibodies</strong> can kill tumors by blocking growth receptors on their cell surface. One of the most effective of these therapeutic antibodies is <strong>Herceptin</strong>, which inhibits the growth of breast cancer cells. Herceptin blocks HER2 growth receptors on breast cancer cells. Thus, if a patient presents with a HER2 breast cancer, the patient’s tumor will respond to treatment with Herceptin.</p><p>In another example of immunotherapy, monoclonal antibodies are used to activate T cell lymphocytes. Normal T cell lymphocytes are capable of recognizing and killing tumor cells but in most cancer patients this response is ineffective due to a built-in brake called a checkpoint on the T cell surface. Monoclonal antibodies can block this checkpoint brake and allow the normal T cell population to expand and destroy the tumor. These antibodies, called <strong>checkpoint inhibitors</strong>, are used to treat melanoma, lymphoma, lung, kidney, bladder and colon cancers. See Table 19-8 for examples of monoclonal antibodies and the cancers they treat.</p>
			</div>

		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="f9c4477f-669b-4099-98a3-39aa39062a0c" class="block-content engine"><div class="static">
		<div class="screen__margin">
			
			<h3 class="heading heading--subheadinga"><span style="color:#007FAD;"><strong>TABLE 19-8 </strong>MONOCLONAL ANTIBODIES AND CANCERS THEY TREAT</span></h3>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="6acb10ee-8484-4355-be9b-56e15a6e06e3" class="block-content engine"><div class="static">
		<div class="screen__margin vst-draggable">
			<div class="c-x-scroll vst-draggable">
					<div class="js-x-scroll c-x-scroll__scrollbox" style=""><table class="c-table js-x-scroll-component" style="width: 100%;" data-orig-width="100%"><thead><tr><th scope="col"><strong>MONOCLONAL ANTIBODIES</strong></th><th scope="col"><strong>CANCERS THEY TREAT</strong></th></tr></thead><tbody><tr><td><strong>Adcetris (brentuximab vedotin)</strong></td><td>Hodgkin lymphoma</td></tr><tr><td><strong>Avastin (bevacizumab)</strong></td><td>colorectal cancer, lung cancer, brain tumors</td></tr><tr><td><strong>Erbitux (cetuximab)</strong></td><td>colorectal cancer, head and neck cancer</td></tr><tr><td><strong>Herceptin (trastuzumab)</strong></td><td>breast cancer, gastric cancer</td></tr><tr><td><strong>Opdivo (nivolumab)</strong></td><td>melanoma, lung cancer, kidney cancer</td></tr><tr><td><strong>Keytruda (pembrolizumab)</strong></td><td>melanoma, lung cancer, colon cancer, bladder cancer</td></tr><tr><td><strong>Rituxan (rituximab)</strong></td><td>CLL and lymphomas</td></tr></tbody></table></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--left"></div>
					<div class="c-x-scroll__gradient c-x-scroll__gradient--right"></div>
				</div>
		</div>
	</div></div>
		
	</div><div class="block rendered">
		<div id="a50cf89b-6ee7-4a84-a384-599643f26079" class="block-content engine"><div class="static">
		<div class="screen__margin">
			<div class="static__text--indent">
				<p><strong><img alt="" class="c-inline-icon" data-handler="inline-image" style="vertical-align: middle; width: 16px; height: 16px;" src="../media/icons.png" data-handler-handled="true" /> Molecularly Targeted Drugs (oncogene inhibitors)</strong>:</p><p>Examples are:</p><p style="margin-left: 40px;"><strong>Gleevec (imatinib) </strong>—used in chronic myeloid leukemia<br /><strong>Tasigna (nilotinib) </strong>—used in chronic myeloid leukemia<br /><strong>Tagrisso (osimertinib)</strong> —used in lung cancer<br /><strong>Cabometyx (cabozantinib)</strong> —used in hepatocellular carcinoma and renal cell carcinoma<br /><strong>Nexavar (sorafenib) </strong>—used in renal cell carcinoma and hepatocellular carcinoma<br /><strong>Imbruvica (ibrutinib) </strong>—used in chronic lymphoid leukemia, lymphoma<br /><strong>Votrient (pazopanib)</strong> —used in sarcomas<br /><strong>Sutent (sunitinib) </strong>—used in renal cell carcinoma and hepatocelluar carcinoma</p>
			</div>

		</div>
	</div></div>
		
	</div></div>
		
		<div class="screengrid">
			<footer class="screen__margin screen__footer u-hide-element vstdonthighlight">
				<div class="feedback">
					<div class="feedback__content js-feedback-focus" tabindex="-1"></div>
				</div>
				<div class="control-btns"></div>
			</footer>
		</div>
	</div><div  class="overlay-root vstdonthighlight rendered blocking" style="overflow-y: auto;">
		<div class="modal-cover-holder">
			<div class="modal-cover-outer"><div class="modal-cover modal-cover--transparent-medium"></div></div>
		</div>
	<div class="loading-spinner rendered" tabindex="-1">
		<!-- Set opacity to 0 inline to prevent screen flash -->
		<div class="spinner-message visuallyhidden" style="opacity: 0">Loading</div>
		<div class="spinner"></div>
	</div></div>
<script type="application/javascript">
	!function(e){var n={eid:"SCREEN",did:"08cbe02a-d2cc-4e65-b0e6-87bf96e9e734",type:"epub",screenType:"Screen",engineApi:{getEnginesBaseUrl:function(){return "../vcsprod_20221215125633UTC-prod";},getMediaBaseUrl:function(){return "../media";},getSkinsBaseUrl:function(){return "../vcsprod_20221215125633UTC-prod/skins_20221215125633UTC-prod/vcs";},getActivityData:function(){return "&lt;blocks&gt;\n  &lt;block refid=\&quot;05933938-cbd7-4322-a69d-0eb56c4aa457\&quot;&gt;\n    &lt;STATIC_heading&gt;\n  &lt;headingLevel value=\&quot;subheadinga\&quot;/&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;&amp;lt;span style=\&quot;color:#684182;\&quot;&amp;gt;&amp;lt;strong&amp;gt;CANCER TREATMENT&amp;lt;/strong&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_heading&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;5e6c6aa8-108b-4d8b-8d26-1a01b266afe1\&quot;&gt;\n    &lt;STATIC_text&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;Major approaches to cancer treatment are &amp;lt;strong&amp;gt;surgery, radiation therapy, chemotherapy, molecularly targeted therapy, &amp;lt;/strong&amp;gt;and &amp;lt;strong&amp;gt;immunotherapy.&amp;lt;/strong&amp;gt; Each &amp;lt;strong&amp;gt;modality &amp;lt;/strong&amp;gt;(method) may be used alone, but often they are used together in combined-modality regimens to improve the overall diagnosis and treatment result.&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_text&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;09d9feff-0dd7-4b12-9895-bc23f1d8b87b\&quot;&gt;\n    &lt;STATIC_heading&gt;\n  &lt;headingLevel value=\&quot;subheadinga\&quot;/&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;&amp;lt;span style=\&quot;color:#007FAD;\&quot;&amp;gt;SURGERY&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_heading&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;2a70064a-93c2-4f5e-aad4-3a620214eef1\&quot;&gt;\n    &lt;STATIC_text&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;In many patients with cancer, the tumor is discovered before it has spread, and it may be cured by surgical excision. Some common cancers in which surgery may be curative are those of the stomach, breast, colon, lung, and uterus (endometrium). In other patients who have metastases, surgical removal of the primary tumor prevents local spread or complications, even in the presence of distant disease. A &amp;lt;strong&amp;gt;debulking procedure&amp;lt;/strong&amp;gt; may be used to remove as much of the primary tumor mass as possible, even if the tumor is attached to a vital organ and cannot be completely removed. After removal of the primary tumor, the patient often receives &amp;lt;strong&amp;gt;adjuvant &amp;lt;/strong&amp;gt;(assisting) radiation therapy and/or chemotherapy to prevent recurrence at local and distant sites.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The following is a list of terms that describe surgical procedures used in diagnosing and treating cancer.&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_text&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;2e968b0a-9863-45f8-bff8-831c46792848\&quot;&gt;\n    &lt;STATIC_table&gt;\n  &lt;text&gt;&amp;lt;table class=\&quot;c-table js-x-scroll-component\&quot; border=\&quot;1\&quot; cellspacing=\&quot;0\&quot; cellpadding=\&quot;1\&quot; style=\&quot;width: 100%;\&quot;&amp;gt;&amp;lt;thead/&amp;gt;&amp;lt;tbody&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;cauterization&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Destruction of tissue by burning. Examples are electrocauterization (using a needle or snare heated by electric current), laser, dry ice, and chemicals.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;core needle biopsy&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Placement of a large-bore needle that extracts a core of tissue.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;cryosurgery&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Use of subfreezing temperature to destroy tissue.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;en bloc resection&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Tumor is removed along with a large area of surrounding tissue containing lymph nodes. Modified radical mastectomy, colectomy, and gastrectomy are examples.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;excisional biopsy&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Removal of tumor and a margin of normal tissue. This procedure provides a specimen for diagnosis and may be curative for small noninvasive tumors.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;exenteration&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Wide resection involving removal of the tumor, its organ of origin, and all surrounding tissue in the body space. Pelvic exenteration with removal of the uterus, ovaries, bladder, and segments of the large bowel may be performed to treat large primary tumors of the uterus.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;fine needle aspiration&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Placement of a very thin needle inside the tumor mass and extracting cells for microscopic evaluation.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;fulguration&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Destruction of tissue by electric sparks generated by a high-frequency current.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;incisional biopsy&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Piece of tumor is removed for examination to establish a diagnosis. More extensive surgical procedure or other forms of treatment, such as chemotherapy or radiation therapy, are then used to treat the bulk of the tumor.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;/tbody&amp;gt;&amp;lt;/table&amp;gt;&lt;/text&gt;\n&lt;/STATIC_table&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;91a4bf65-e909-4ad1-9398-d147992f5293\&quot;&gt;\n    &lt;STATIC_heading&gt;\n  &lt;headingLevel value=\&quot;subheadinga\&quot;/&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;&amp;lt;span style=\&quot;color:#007FAD;\&quot;&amp;gt;RADIATION THERAPY (RADIATION ONCOLOGY)&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_heading&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;aa69478a-33a6-4571-81df-0657b8614d4e\&quot;&gt;\n    &lt;STATIC_text&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;The &amp;lt;strong&amp;gt;goal of radiation therapy (RT)&amp;lt;/strong&amp;gt; is to deliver a maximal dose of ionizing radiation to the tumor tissue and a minimal dose to the surrounding normal tissue. High-dose &amp;lt;strong&amp;gt;irradiation&amp;lt;/strong&amp;gt; (exposure of tissue to radiation) destroys tumor cells and produces damage to DNA. Newer techniques of irradiation use high-energy beams of &amp;lt;strong&amp;gt;protons &amp;lt;/strong&amp;gt;(subatomic particles) to improve the uniformity (conformality) of dose and to limit damage to normal tissues.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Terms used in the field of radiation therapy for cancer are as follows:&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_text&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;17286944-ac54-4bda-94db-0b1ba8a948ec\&quot;&gt;\n    &lt;STATIC_table&gt;\n  &lt;text&gt;&amp;lt;table class=\&quot;c-table js-x-scroll-component\&quot; border=\&quot;1\&quot; cellspacing=\&quot;0\&quot; cellpadding=\&quot;1\&quot; style=\&quot;width: 100%;\&quot;&amp;gt;&amp;lt;thead/&amp;gt;&amp;lt;tbody&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;brachytherapy&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Implantation of small, sealed containers or seeds of radioactive material directly into the tumor (interstitial therapy); or in a cavity of the tumor (intracavitary therapy, as in endometrial cancer). An implant may be temporary (as in treatment for tumors of the head and neck or gynecologic malignancies) or permanent (as with prostatic implants, or “seeds,” placed into the affected area of the gland).&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;electron beams&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Low-energy beams for treatment of skin or surface tumors.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;external beam irradiation (teletherapy)&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Radiation therapy applied to a tumor from a distant source (linear accelerator).&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;fractionation&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;A method of dividing radiation into small, repeated doses rather than fewer large doses. Fractionation allows larger total doses to be given while causing less damage to normal tissue.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;gray (Gy)&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Unit of absorbed radiation dose. Historically, the unit in use was rad (100 rad equal 1 Gy).&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;linear accelerator&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Large electronic device that produces high-energy x-ray (or photon) beams for the treatment of deep-seated tumors (Figure 19-9). Intraoperative radiation therapy (IORT) is direct application of radiation during surgery using a linear accelerator in the operating room.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;photon therapy&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Radiation therapy using x-rays or gamma rays. A linear accelerator produces photon beams to treat tumors. See &amp;lt;em&amp;gt;&amp;lt;strong&amp;gt;In Person: Radiotherapy&amp;lt;/strong&amp;gt;&amp;lt;/em&amp;gt;.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;/tbody&amp;gt;&amp;lt;/table&amp;gt;&lt;/text&gt;\n&lt;/STATIC_table&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;89620104-2057-42f4-9c06-de41050a3a82\&quot;&gt;\n    &lt;STATIC_figure&gt;\n  &lt;image&gt;page_629_02.jpg&lt;/image&gt;\n  &lt;imageControls&gt;\n    &lt;imageScale value=\&quot;1-2-screen\&quot;/&gt;\n    &lt;imageAlignment value=\&quot;center\&quot;/&gt;\n    &lt;enableZoom value=\&quot;on\&quot;/&gt;\n    &lt;searchableImage value=\&quot;on\&quot;/&gt;\n    &lt;legacyErrorLabel/&gt;\n    &lt;enableBorder value=\&quot;off\&quot;/&gt;\n  &lt;/imageControls&gt;\n  &lt;imageCaption&gt;&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;&amp;lt;span style=\&quot;color:#D81E5D;\&quot;&amp;gt;FIGURE 19-9 &amp;lt;/span&amp;gt;Linear accelerator.&amp;lt;/strong&amp;gt; Radiation therapy (photon therapy) delivered to a patient positioned under a linear accelerator.&amp;lt;strong&amp;gt; Intensity-modulated radiation therapy (IMRT) &amp;lt;/strong&amp;gt;is an advanced mode of high-precision radiotherapy that uses computercontrolled linear accelerators to deliver precise radiation doses to a malignant tumor. This is a type of &amp;lt;strong&amp;gt;conformal radiation therapy&amp;lt;/strong&amp;gt; that uses computer technology to create a three-dimensional image of a tumor so that rotating beams can shape exactly to the contour of the tumor. &amp;lt;em&amp;gt;(Courtesy Arthur Brimberg, MD, Riverhill Radiation Oncology, Yonkers, New York.)&amp;lt;/em&amp;gt;&amp;lt;/p&amp;gt;&lt;/imageCaption&gt;\n  &lt;imageAlt/&gt;\n&lt;/STATIC_figure&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;8231f011-37ee-4e6e-bf5a-55acf4a07c8a\&quot;&gt;\n    &lt;STATIC_table&gt;\n  &lt;text&gt;&amp;lt;table class=\&quot;c-table js-x-scroll-component\&quot; border=\&quot;1\&quot; cellspacing=\&quot;0\&quot; cellpadding=\&quot;1\&quot; style=\&quot;width: 100%;\&quot;&amp;gt;&amp;lt;thead/&amp;gt;&amp;lt;tbody&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;proton therapy&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Small subatomic positively charged particles (protons) produced by a cyclotron deposit all the energy at a focused finite point. This reduces the dose affecting normal surrounding tissues by at least 50% (Figure 19-10).&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;radiation fields&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Dimensions of the size of radiation area used to treat a tumor from a specific angle. See Figure 19-11.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;radiocurable tumor&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Tumor that can be completely eradicated by radiation therapy. Usually, this is a localized tumor with no evidence of metastasis. Lymphomas, Hodgkin lymphoma, and seminomas of the testes are examples.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;radioresistant tumor&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Tumor that requires large doses of radiation to produce death of the cells. Melanoma and renal carcinoma are among the most radioresistant tumors.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;radiosensitive tumor&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Tumor in which irradiation can cause the death of cells without serious damage to surrounding tissue (morbidity). Tumors of hematopoietic (blood-forming) and lymphatic origins are radiosensitive.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;radiosensitizers&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Drugs that increase the sensitivity of tumors to x-rays. Many cancer chemotherapy drugs, especially 5-fluorouracil and cisplatin, sensitize tumors and normal tissue to radiation, thereby improving the outcome of treatment.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;radiosensitizers&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;An imaging study performed before radiation therapy using CT scan and/or MRI to map the area to receive treatment. Simulation is required for all patients undergoing radiotherapy.&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;stereotactic radiosurgery&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Single large dose of radiation is delivered under precise three-dimensional (3D) guidance (stereotactic) from multiple angles to destroy vascular abnormalities and small brain tumors (see Figure 19-10B).&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;/tbody&amp;gt;&amp;lt;/table&amp;gt;&lt;/text&gt;\n&lt;/STATIC_table&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;46e29d8c-0cd5-4560-95b6-2b5c5bfe67a3\&quot;&gt;\n    &lt;STATIC_figure&gt;\n  &lt;image&gt;chp00019_f019-010-9780323551472.jpg&lt;/image&gt;\n  &lt;imageControls&gt;\n    &lt;imageScale value=\&quot;3-4-screen\&quot;/&gt;\n    &lt;imageAlignment value=\&quot;center\&quot;/&gt;\n    &lt;enableZoom value=\&quot;on\&quot;/&gt;\n    &lt;searchableImage value=\&quot;on\&quot;/&gt;\n    &lt;legacyErrorLabel/&gt;\n    &lt;enableBorder value=\&quot;off\&quot;/&gt;\n  &lt;/imageControls&gt;\n  &lt;imageCaption&gt;&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;&amp;lt;span style=\&quot;color:#D81E5D;\&quot;&amp;gt;FIGURE 19-10 &amp;lt;/span&amp;gt;A, Proton therapy machine. &amp;lt;/strong&amp;gt;Proton beam radiation therapy is useful in treating a variety of cancers including tumors of the head and neck, brain, eye, and prostate. The beam can rotate to different positions around the patient. &amp;lt;strong&amp;gt;B, Proton stereotactic radiosurgery.&amp;lt;/strong&amp;gt; A model poses to show how a proton beam device is brought near a patient in preparation for stereotactic radiosurgery. &amp;lt;em&amp;gt;(Courtesy Jay Loeffler, MD, Chief, Radiation Oncology Department, Massachusetts General Hospital, Boston.)&amp;lt;/em&amp;gt;&amp;lt;/p&amp;gt;&lt;/imageCaption&gt;\n  &lt;imageAlt/&gt;\n&lt;/STATIC_figure&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;0d10e292-0e2c-427a-9b6b-69bc18f924ff\&quot;&gt;\n    &lt;STATIC_figure&gt;\n  &lt;image&gt;chp00019_f019-011-9780323551472.jpg&lt;/image&gt;\n  &lt;imageControls&gt;\n    &lt;imageScale value=\&quot;3-4-screen\&quot;/&gt;\n    &lt;imageAlignment value=\&quot;center\&quot;/&gt;\n    &lt;enableZoom value=\&quot;on\&quot;/&gt;\n    &lt;searchableImage value=\&quot;on\&quot;/&gt;\n    &lt;legacyErrorLabel/&gt;\n    &lt;enableBorder value=\&quot;off\&quot;/&gt;\n  &lt;/imageControls&gt;\n  &lt;imageCaption&gt;&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;&amp;lt;span style=\&quot;color:#D81E5D;\&quot;&amp;gt;FIGURE 19-11 &amp;lt;/span&amp;gt;Radiation fields.&amp;lt;/strong&amp;gt; Three-color radiation dose distribution image showing radiation fields used to treat a brain tumor. &amp;lt;em&amp;gt;(Courtesy of Jay Loeffler, MD, Chief, Radiation Oncology Department, Massachusetts General Hospital, Boston.)&amp;lt;/em&amp;gt;&amp;lt;/p&amp;gt;&lt;/imageCaption&gt;\n  &lt;imageAlt/&gt;\n&lt;/STATIC_figure&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;9999f016-2aff-4a40-8929-e1761ba3a290\&quot;&gt;\n    &lt;STATIC_text&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;Radiotherapy, although it may be either &amp;lt;strong&amp;gt;palliative &amp;lt;/strong&amp;gt;(relieving symptoms) or curative, can produce undesirable side effects to any normal body tissues that are caught in the field of irradiation. Some complications due to irradiation of normal tissue surrounding the tumor and in the path of the beam of photons may be reversible with time, and recovery takes place soon after radiotherapy is completed. Side effects may be acute (days to weeks after first dose), subacute (several weeks or months later), or late (months to years later). Radiation side effects are listed in Table 19-6.&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_text&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;ef318a28-b6be-4911-9547-61f0e68c8813\&quot;&gt;\n    &lt;STATIC_heading&gt;\n  &lt;headingLevel value=\&quot;subheadinga\&quot;/&gt;\n  &lt;text&gt;&amp;lt;span style=\&quot;color:#007FAD;\&quot;&amp;gt;&amp;lt;strong&amp;gt;TABLE 19-6&amp;lt;/strong&amp;gt; RADIOTHERAPY SIDE EFFECTS&amp;lt;/span&amp;gt;&lt;/text&gt;\n&lt;/STATIC_heading&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;9faae86b-cb9d-4e36-bd71-ed7c74714df3\&quot;&gt;\n    &lt;STATIC_table&gt;\n  &lt;text&gt;&amp;lt;table class=\&quot;c-table js-x-scroll-component\&quot; border=\&quot;1\&quot; cellspacing=\&quot;0\&quot; cellpadding=\&quot;1\&quot; style=\&quot;width: 100%;\&quot;&amp;gt;&amp;lt;thead/&amp;gt;&amp;lt;tbody&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=\&quot;2\&quot;&amp;gt;&amp;lt;strong&amp;gt;Acute&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;mucositis&amp;lt;/strong&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;inflammation and ulceration of mucous membranes (mouth, pharynx, vagina, bladder, large or small intestine)&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;myelosuppression&amp;lt;/strong&amp;gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;bone marrow depression (anemia, leukopenia, and thrombocytopenia)&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;nausea and vomiting&amp;lt;/strong&amp;gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;uneasiness of the stomach and emptying of its contents— more common with irradiation of the brain and gastrointestinal tract&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;xerostomia&amp;lt;/strong&amp;gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;dryness of the mouth—with salivary gland irradiation&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=\&quot;2\&quot;&amp;gt;&amp;lt;strong&amp;gt;Subacute&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;alopecia&amp;lt;/strong&amp;gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;baldness (permanent or temporary)&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;cystitis&amp;lt;/strong&amp;gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;inflammation of the urinary bladder&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;pneumonitis&amp;lt;/strong&amp;gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;inflammation of the lungs&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;proctitis&amp;lt;/strong&amp;gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;inflammation of the rectum and anus&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=\&quot;2\&quot;&amp;gt;&amp;lt;strong&amp;gt;Late&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;fibrosis&amp;lt;/strong&amp;gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;increase of connective tissue (scarring of skin, lungs, kidneys)&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;secondary tumors&amp;lt;/strong&amp;gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;new types of tumors in separate sites (leukemias and solid tumors such as carcinomas and sarcomas)&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;ul&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;infertility&amp;lt;/strong&amp;gt;&amp;lt;/li&amp;gt;&amp;lt;/ul&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;&amp;lt;p&amp;gt;loss of reproductive function&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt; &amp;lt;/p&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;/tbody&amp;gt;&amp;lt;/table&amp;gt;&lt;/text&gt;\n&lt;/STATIC_table&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;baedc06e-6b41-468f-be7f-281d32b8b8a1\&quot;&gt;\n    &lt;STATIC_heading&gt;\n  &lt;headingLevel value=\&quot;subheadinga\&quot;/&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;&amp;lt;span style=\&quot;color:#007FAD;\&quot;&amp;gt;CHEMOTHERAPY&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_heading&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;e4e47a4b-29a6-42b1-aa1d-cdab163fd44e\&quot;&gt;\n    &lt;STATIC_text&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Cancer chemotherapy&amp;lt;/strong&amp;gt; is the treatment of cancer using chemicals (drugs). It is the standard treatment for many types of cancer, and is curative in a number of them, such as testicular cancer, acute lymphocytic leukemia (children), and Hodgkin lymphoma, and large cell lymphomas. Chemotherapy may be used alone or in combination with surgery and irradiation to improve cure rates.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Drugs cause tumor cells to die by damaging their DNA. Tumor cells with damaged DNA undergo apoptosis (self-destruction). This means that they have less capacity to repair their DNA and, in general, are less able to survive DNA damage caused by drugs and radiation.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The ideal is to administer drugs that kill large numbers of tumor cells without harming normal cells. However, rapidly dividing normal cells, such as in the bone marrow and gastrointestinal lining, can suffer considerable damage from chemotherapeutic drugs. Research physicians measure drug levels and disappearance from the bloodstream and tissues. They use information from animal experiments and &amp;lt;strong&amp;gt;clinical trials &amp;lt;img alt=\&quot;\&quot; class=\&quot;c-inline-icon\&quot; data-handler=\&quot;inline-image\&quot; style=\&quot;vertical-align: middle; width: 16px; height: 16px;\&quot; src=\&quot;../media/icons.png\&quot; data-handler-handled=\&quot;true\&quot;/&amp;gt;&amp;lt;/strong&amp;gt; to design better routes and schedules of administration to achieve the greatest tumor kill with the least toxicity (harm) to normal cells.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Combination chemotherapy &amp;lt;/strong&amp;gt;is the use of two or more drugs together to kill tumors. Drugs are given according to a written &amp;lt;strong&amp;gt;protocol&amp;lt;/strong&amp;gt;, or plan, that details the route, schedule, and frequency of doses. Usually, drug therapy is continued until the patient achieves a complete &amp;lt;strong&amp;gt;remission &amp;lt;/strong&amp;gt;(absence of all signs of disease).&amp;lt;strong&amp;gt; Adjuvant chemotherapy&amp;lt;/strong&amp;gt; is the administration of drug treatment after surgery to kill any residual cancer cells. &amp;lt;strong&amp;gt;Neoadjuvant chemotherapy &amp;lt;/strong&amp;gt;is administrated before surgery to reduce the size of a tumor, such as breast or head and neck cancer. Neoadjuvant drug treatment allows for a lesser surgery and improvement of outcome.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The following are categories of cancer chemotherapeutic agents. Each works by disrupting cell function so that cancer cells die. At the same time, normal cells may be damaged as well. In each category, side effects such as alopecia, nausea and vomiting, and myelosuppression (suppression of bone marrow) can occur.&amp;lt;/p&amp;gt;&amp;lt;ol&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;Alkylating agents.&amp;lt;/strong&amp;gt; These drugs cause crosslinks and breaks in DNA that interfere with cell division. &amp;lt;strong&amp;gt;Cisplatin (Platinol) &amp;lt;/strong&amp;gt;and &amp;lt;strong&amp;gt;cyclophosphamide (Cytoxan) &amp;lt;/strong&amp;gt;are examples.&amp;lt;/li&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;Antibiotics.&amp;lt;/strong&amp;gt; These drugs are produced by bacteria or fungi and inhibit cell division by causing breaks in DNA strands. &amp;lt;strong&amp;gt;Doxorubicin (Adriamycin)&amp;lt;/strong&amp;gt; is an example.&amp;lt;/li&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;Antimetabolites. &amp;lt;/strong&amp;gt;These drugs block synthesis of DNA components (nucleotides) and prevent cells from dividing. &amp;lt;strong&amp;gt;Methotrexate and 5-fluorouracil (5FU)&amp;lt;/strong&amp;gt; are examples.&amp;lt;/li&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;Antimitotics.&amp;lt;/strong&amp;gt; These chemicals block the function of a protein that is necessary for mitosis (cell division). Antimitotic drugs are derived from bacteria, fungi or plants, or from small sea animals found on coral reefs.&amp;lt;strong&amp;gt; Paclitaxel (Taxol) &amp;lt;/strong&amp;gt;is an example.&amp;lt;/li&amp;gt;&amp;lt;li&amp;gt;&amp;lt;strong&amp;gt;Hormonal agents. &amp;lt;/strong&amp;gt;These drugs block hormone receptors on cells so that growth is inhibited. An example is &amp;lt;strong&amp;gt;tamoxifen (Novadex)&amp;lt;/strong&amp;gt;, which blocks an &amp;lt;strong&amp;gt;estrogen receptor &amp;lt;/strong&amp;gt;on breast cancer cells. Aromatase inhibitors, such as&amp;lt;strong&amp;gt; anastrozole (Arimidex)&amp;lt;/strong&amp;gt; prevent the conversion of androgen to estrogen and starve breast tumors of their estrogen supply in women who have gone through menopause (age greater than 50).&amp;lt;/li&amp;gt;&amp;lt;/ol&amp;gt;&amp;lt;p&amp;gt;Figure 19-12 illustrates the mechanisms of action for various types of cancer che motherapeutic agents. Often, drugs are administered in combination, according to carefully planned &amp;lt;strong&amp;gt;protocols &amp;lt;/strong&amp;gt;(regimens). For your reference, see Table 19-7 which lists specific chemotherapeutic drugs in each category and the type of cancer they treat.&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_text&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;3d8090dd-8cf7-43e1-8551-813a79d2a0bb\&quot;&gt;\n    &lt;STATIC_text&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;&amp;lt;img alt=\&quot;\&quot; class=\&quot;c-inline-icon\&quot; data-handler=\&quot;inline-image\&quot; style=\&quot;vertical-align: middle; width: 16px; height: 16px;\&quot; src=\&quot;../media/icons.png\&quot; data-handler-handled=\&quot;true\&quot;/&amp;gt; &amp;lt;strong&amp;gt;Clinical Trials&amp;lt;/strong&amp;gt;: Clinical trials are research studies designed to find treatments that work better than the standard therapies for patients. The studies follow a predefined protocol and are divided into four phases:&amp;lt;/p&amp;gt;&amp;lt;p style=\&quot;margin-left: 40px;\&quot;&amp;gt;&amp;lt;strong&amp;gt;Phase I:&amp;lt;/strong&amp;gt; The experimental drug or treatment is tested in a small group of people (20 to 80) for the first time to evaluate its safety. Phase I trials also determine a safe dosage range and schedule of administration (daily, weekly, or every 3 weeks, oral or intravenous, and so on).&amp;lt;/p&amp;gt;&amp;lt;p style=\&quot;margin-left: 40px;\&quot;&amp;gt;&amp;lt;strong&amp;gt;Phase II:&amp;lt;/strong&amp;gt; Experimental treatment is given to a larger group of subjects (100–200) with a specific type of cancer to identify tumor response rate and define safety risks.&amp;lt;/p&amp;gt;&amp;lt;p style=\&quot;margin-left: 40px;\&quot;&amp;gt;&amp;lt;strong&amp;gt;Phase III: &amp;lt;/strong&amp;gt;A larger and more definitive trial is conducted in which hundreds or thousands of subjects take part. Patients are randomly assigned to the new treatment or to a standard, established treatment. The effectiveness and overall risk-versus-benefit ratio for the experimental treatment are compared with the results of those for standard treatment. A new drug may be approved by the FDA (U.S. Food and Drug Administration) based on these results.&amp;lt;/p&amp;gt;&amp;lt;p style=\&quot;margin-left: 40px;\&quot;&amp;gt;&amp;lt;strong&amp;gt;Phase IV: &amp;lt;/strong&amp;gt;Large studies are conducted after the FDA has granted its initial approval of a new treatment for marketing. These trials are designed to monitor safety in large populations and identify new indications and new drug combinations beyond those already approved.&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_text&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;f2a66399-644c-42ab-b720-7c393e514844\&quot;&gt;\n    &lt;STATIC_figure&gt;\n  &lt;image&gt;chp00019_f019-012-9780323551472.jpg&lt;/image&gt;\n  &lt;imageControls&gt;\n    &lt;imageScale value=\&quot;3-4-screen\&quot;/&gt;\n    &lt;imageAlignment value=\&quot;center\&quot;/&gt;\n    &lt;enableZoom value=\&quot;on\&quot;/&gt;\n    &lt;searchableImage value=\&quot;on\&quot;/&gt;\n    &lt;legacyErrorLabel/&gt;\n    &lt;enableBorder value=\&quot;off\&quot;/&gt;\n  &lt;/imageControls&gt;\n  &lt;imageCaption&gt;&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;&amp;lt;span style=\&quot;color:#D81E5D;\&quot;&amp;gt;FIGURE 19-12 &amp;lt;/span&amp;gt;Mechanisms of action of cancer chemotherapeutic agents.&amp;lt;/strong&amp;gt;&amp;lt;/p&amp;gt;&lt;/imageCaption&gt;\n  &lt;imageAlt/&gt;\n&lt;/STATIC_figure&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;e0b078d1-8ace-41a6-8663-33760f643ac1\&quot;&gt;\n    &lt;STATIC_heading&gt;\n  &lt;headingLevel value=\&quot;subheadinga\&quot;/&gt;\n  &lt;text&gt;&amp;lt;span style=\&quot;color:#007FAD;\&quot;&amp;gt;&amp;lt;strong&amp;gt;TABLE 19-7&amp;lt;/strong&amp;gt; SELECTED CANCER CHEMOTHERAPEUTIC AGENTS AND THE CANCERS THEY TREAT&amp;lt;/span&amp;gt;&lt;/text&gt;\n&lt;/STATIC_heading&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;4d6b27fa-e32b-42ff-971e-acbda03b3784\&quot;&gt;\n    &lt;STATIC_table&gt;\n  &lt;text&gt;&amp;lt;table class=\&quot;c-table js-x-scroll-component\&quot; border=\&quot;1\&quot; cellspacing=\&quot;0\&quot; cellpadding=\&quot;1\&quot; style=\&quot;width: 100%;\&quot;&amp;gt;&amp;lt;thead&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;th scope=\&quot;col\&quot;&amp;gt;&amp;lt;strong&amp;gt;CHEMOTHERAPEUTIC AGENT&amp;lt;/strong&amp;gt;&amp;lt;/th&amp;gt;&amp;lt;th scope=\&quot;col\&quot;&amp;gt;&amp;lt;strong&amp;gt;TYPE OF CANCER&amp;lt;/strong&amp;gt;&amp;lt;/th&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;/thead&amp;gt;&amp;lt;tbody&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=\&quot;2\&quot;&amp;gt;&amp;lt;strong&amp;gt;Alkylating Agents&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Bendamustine (Ribomustine)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Non-Hodgkin lymphoma&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Cisplatin (Platinol)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Testicular; ovarian&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Cyclophosphamide (Cytoxan)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Lymphoma&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Temozolomide (Temodar)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Brain (glioma)&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=\&quot;2\&quot;&amp;gt;&amp;lt;strong&amp;gt;Antibiotics&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Bleomycin (Blenoxane)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Testicular, Hodgkin lymphoma&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Daunorubicin (Cerubidine)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acute myeloid leukemia (AML)&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Doxorubicin (Adriamycin, Doxil)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Breast&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=\&quot;2\&quot;&amp;gt;&amp;lt;strong&amp;gt;Antimetabolites&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Cytarabine (ara-C, Cytosar-U)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;AML&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Fludarabine (Fludara)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Chronic lymphoid leukemia (CLL)&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;5-Fluorouracil (5-FU) (various)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Colon&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Methotrexate, MTX (Folex, Mexate)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Acute lymphoid leukemia (ALL)&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Pemetrexed (Alimta)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Lung&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;Antimitotics&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt; &amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Docetaxel (Taxotere)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Breast, lung&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Paclitaxel (Taxol)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Breast, ovarian, lung&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Vincristine (Oncovin)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Lymphoma&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td colspan=\&quot;2\&quot;&amp;gt;&amp;lt;strong&amp;gt;Hormones and Hormone Antagonists&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Abiraterone (Zytiga)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Prostate&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Anastrozole (Arimidex)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Breast&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Dexamethasone (Decadron)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Lymphoma&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Leuprolide (Lupron)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Prostate&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;Tamoxifen (Nolvadex)&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Breast&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;/tbody&amp;gt;&amp;lt;/table&amp;gt;&amp;lt;p&amp;gt;&amp;lt;em&amp;gt;Note&amp;lt;/em&amp;gt;: Brand names are in parentheses. Often drugs are given in combinations according to carefully planned regimens called &amp;lt;strong&amp;gt;protocols&amp;lt;/strong&amp;gt;.&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_table&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;b2bcd353-a888-44e3-8e1b-bc86372e5483\&quot;&gt;\n    &lt;STATIC_heading&gt;\n  &lt;headingLevel value=\&quot;subheadinga\&quot;/&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;&amp;lt;span style=\&quot;color:#007FAD;\&quot;&amp;gt;MOLECULARLY TARGETED THERAPY&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_heading&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;3bf1a03e-7965-4748-9cc3-3f2720b5748c\&quot;&gt;\n    &lt;STATIC_text&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;Molecularly targeted cancer therapy uses drugs to attack specific oncogenic mutations (targets) that drive cancer cell growth. When these targets are blocked by drugs, the cancer cell dies. Some of the targets are absolutely unique to tumor cells and not found in normal tissues. Thus, in contrast with chemotherapy, blocking these targets will have little or no effect on normal cells. Chemotherapeutic drugs normally are delivered by intravenous infusion, whereas molecularly targeted drugs &amp;lt;img alt=\&quot;\&quot; class=\&quot;c-inline-icon\&quot; data-handler=\&quot;inline-image\&quot; style=\&quot;vertical-align: middle; width: 16px; height: 16px;\&quot; src=\&quot;../media/icons.png\&quot; data-handler-handled=\&quot;true\&quot;/&amp;gt; often are mostly given in pill form.&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_text&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;f6fd2f52-70dc-457c-bd61-135ce91f9428\&quot;&gt;\n    &lt;STATIC_heading&gt;\n  &lt;headingLevel value=\&quot;subheadinga\&quot;/&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;&amp;lt;span style=\&quot;color:#007FAD;\&quot;&amp;gt;IMMUNOTHERAPY&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_heading&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;2deaefea-6c2d-499d-b79b-f90ebe8204a0\&quot;&gt;\n    &lt;STATIC_text&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;Immunotherapy is the use of immune cells (lymphocytes) or antibodies, to kill tumors. It is now possible to remove a patient’s own T cell lymphocytes and, in the laboratory, introduce new receptors,&amp;lt;strong&amp;gt; CARs (chimeric antigen receptors)&amp;lt;/strong&amp;gt;, on their cell surface. These CAR receptors are designed to bind to the CD19 protein found on the surface of all B-cell tumors. The engineered &amp;lt;strong&amp;gt;CAR T-cells&amp;lt;/strong&amp;gt; can then be infused into the patient, where they attack and destroy the patient’s B-cell tumors. This therapy is effective against all B-cell tumors, including acute lymphoid leukemia (ALL), chronic lymphoid leukemia (CLL), and lymphomas.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Other immunotherapies depend on laboratory engineered antibodies, called monoclonal antibodies. These &amp;lt;strong&amp;gt;monoclonal antibodies&amp;lt;/strong&amp;gt; can kill tumors by blocking growth receptors on their cell surface. One of the most effective of these therapeutic antibodies is &amp;lt;strong&amp;gt;Herceptin&amp;lt;/strong&amp;gt;, which inhibits the growth of breast cancer cells. Herceptin blocks HER2 growth receptors on breast cancer cells. Thus, if a patient presents with a HER2 breast cancer, the patient’s tumor will respond to treatment with Herceptin.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;In another example of immunotherapy, monoclonal antibodies are used to activate T cell lymphocytes. Normal T cell lymphocytes are capable of recognizing and killing tumor cells but in most cancer patients this response is ineffective due to a built-in brake called a checkpoint on the T cell surface. Monoclonal antibodies can block this checkpoint brake and allow the normal T cell population to expand and destroy the tumor. These antibodies, called &amp;lt;strong&amp;gt;checkpoint inhibitors&amp;lt;/strong&amp;gt;, are used to treat melanoma, lymphoma, lung, kidney, bladder and colon cancers. See Table 19-8 for examples of monoclonal antibodies and the cancers they treat.&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_text&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;f9c4477f-669b-4099-98a3-39aa39062a0c\&quot;&gt;\n    &lt;STATIC_heading&gt;\n  &lt;headingLevel value=\&quot;subheadinga\&quot;/&gt;\n  &lt;text&gt;&amp;lt;span style=\&quot;color:#007FAD;\&quot;&amp;gt;&amp;lt;strong&amp;gt;TABLE 19-8 &amp;lt;/strong&amp;gt;MONOCLONAL ANTIBODIES AND CANCERS THEY TREAT&amp;lt;/span&amp;gt;&lt;/text&gt;\n&lt;/STATIC_heading&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;6acb10ee-8484-4355-be9b-56e15a6e06e3\&quot;&gt;\n    &lt;STATIC_table&gt;\n  &lt;text&gt;&amp;lt;table class=\&quot;c-table js-x-scroll-component\&quot; border=\&quot;1\&quot; cellspacing=\&quot;0\&quot; cellpadding=\&quot;1\&quot; style=\&quot;width: 100%;\&quot;&amp;gt;&amp;lt;thead&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;th scope=\&quot;col\&quot;&amp;gt;&amp;lt;strong&amp;gt;MONOCLONAL ANTIBODIES&amp;lt;/strong&amp;gt;&amp;lt;/th&amp;gt;&amp;lt;th scope=\&quot;col\&quot;&amp;gt;&amp;lt;strong&amp;gt;CANCERS THEY TREAT&amp;lt;/strong&amp;gt;&amp;lt;/th&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;/thead&amp;gt;&amp;lt;tbody&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;Adcetris (brentuximab vedotin)&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;Hodgkin lymphoma&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;Avastin (bevacizumab)&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;colorectal cancer, lung cancer, brain tumors&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;Erbitux (cetuximab)&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;colorectal cancer, head and neck cancer&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;Herceptin (trastuzumab)&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;breast cancer, gastric cancer&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;Opdivo (nivolumab)&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;melanoma, lung cancer, kidney cancer&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;Keytruda (pembrolizumab)&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;melanoma, lung cancer, colon cancer, bladder cancer&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;tr&amp;gt;&amp;lt;td&amp;gt;&amp;lt;strong&amp;gt;Rituxan (rituximab)&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;&amp;lt;td&amp;gt;CLL and lymphomas&amp;lt;/td&amp;gt;&amp;lt;/tr&amp;gt;&amp;lt;/tbody&amp;gt;&amp;lt;/table&amp;gt;&lt;/text&gt;\n&lt;/STATIC_table&gt;\n  &lt;/block&gt;\n  &lt;block refid=\&quot;a50cf89b-6ee7-4a84-a384-599643f26079\&quot;&gt;\n    &lt;STATIC_text&gt;\n  &lt;text&gt;&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;&amp;lt;img alt=\&quot;\&quot; class=\&quot;c-inline-icon\&quot; data-handler=\&quot;inline-image\&quot; style=\&quot;vertical-align: middle; width: 16px; height: 16px;\&quot; src=\&quot;../media/icons.png\&quot; data-handler-handled=\&quot;true\&quot;/&amp;gt; Molecularly Targeted Drugs (oncogene inhibitors)&amp;lt;/strong&amp;gt;:&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Examples are:&amp;lt;/p&amp;gt;&amp;lt;p style=\&quot;margin-left: 40px;\&quot;&amp;gt;&amp;lt;strong&amp;gt;Gleevec (imatinib) &amp;lt;/strong&amp;gt;—used in chronic myeloid leukemia&amp;lt;br/&amp;gt;&amp;lt;strong&amp;gt;Tasigna (nilotinib) &amp;lt;/strong&amp;gt;—used in chronic myeloid leukemia&amp;lt;br/&amp;gt;&amp;lt;strong&amp;gt;Tagrisso (osimertinib)&amp;lt;/strong&amp;gt; —used in lung cancer&amp;lt;br/&amp;gt;&amp;lt;strong&amp;gt;Cabometyx (cabozantinib)&amp;lt;/strong&amp;gt; —used in hepatocellular carcinoma and renal cell carcinoma&amp;lt;br/&amp;gt;&amp;lt;strong&amp;gt;Nexavar (sorafenib) &amp;lt;/strong&amp;gt;—used in renal cell carcinoma and hepatocellular carcinoma&amp;lt;br/&amp;gt;&amp;lt;strong&amp;gt;Imbruvica (ibrutinib) &amp;lt;/strong&amp;gt;—used in chronic lymphoid leukemia, lymphoma&amp;lt;br/&amp;gt;&amp;lt;strong&amp;gt;Votrient (pazopanib)&amp;lt;/strong&amp;gt; —used in sarcomas&amp;lt;br/&amp;gt;&amp;lt;strong&amp;gt;Sutent (sunitinib) &amp;lt;/strong&amp;gt;—used in renal cell carcinoma and hepatocelluar carcinoma&amp;lt;/p&amp;gt;&lt;/text&gt;\n&lt;/STATIC_text&gt;\n  &lt;/block&gt;\n&lt;/blocks&gt;";}}};e.context=n}(window);
</script>

</body>
</html>
